Gerald D. Cagle, Director at Clearside Biomedical, Inc. (CLSD), bought 5,000 shares at $6.84 ($34K) on 2017-03-16, disclosed to the SEC on 2017-03-20.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| AERI | BUY | 2018-05-25 | $49K | — | Filing → |
| AERI | BUY | 2018-05-22 | $50K | — | Filing → |
| CLSD | BUY | 2018-03-23 | $89K | — | Filing → |